Information:
Fel:
ID
34320
Beskrivning
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT01590641
Länk
https://clinicaltrials.gov/show/NCT01590641
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis B NCT01590641
Eligibility Hepatitis B NCT01590641
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis B NCT01590641
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
chronic hbv infection ≥ 6 months
boolean
ID.2
Item
hbsag ≥ 250 iu/ml
boolean
ID.3
Item
hbv treatment naïve
boolean
ID.4
Item
absence of extensive bridging fibrosis (metavir 3 or greater) or cirrhosis
boolean
ID.5
Item
creatinine clearance ≥ 70 ml/min
boolean
ID.6
Item
co-infection with hepatitis c virus (hcv), hepatitis d virus (hdv), or hiv
boolean
ID.7
Item
history of gilberts disease
boolean
ID.8
Item
laboratory parameters not within defined thresholds for leukopenia, neutropenia, anemia, thrombocytopenia, thyroid-stimulating hormone (tsh), or other evidence of hepatic decompensation
boolean
ID.9
Item
diagnosis of autoimmune disease, poorly controlled diabetes mellitus, significant psychiatric illness, severe chronic obstructive pulmonary disease(copd), malignancy, hemoglobinopathy, retinal disease, or patients who are immunosuppressed
boolean
ID.10
Item
evidence of hepatocellular carcinoma
boolean